May 20, 2019 - Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs
May 20, 2019 - AbbVie's (ABBV) phase III study on Depatux-M, an investigational candidate for newly diagnosed glioblastoma, fails to show survival benefit in patients receiving Depatux-M.
May 17, 2019 - FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
May 16, 2019 - Geron hints at a way forward for imetelstat in myelofibrosis, but the market isn't buying it.
May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
May 02, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Apr 30, 2019 - If you're looking to follow a master, Buffett is a good place to start. Though sometimes it pays to go back and double-check his moves.
Apr 30, 2019 - There's a clear and present danger to many healthcare stocks that's more serious than anything ever before. Here's what you need to know.
Apr 23, 2019 - Prescription drug sales, the future of Hulu, and more.
Apr 18, 2019 - Let's have a look at some of the highlights of J&J's (JNJ) first-quarter 2019 results.